Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.

@article{Vickerman2012CanNA,
  title={Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.},
  author={Peter Vickerman and Natasha Kaleta Martin and Katherine M E Turner and Matthew Hickman},
  journal={Addiction},
  year={2012},
  volume={107 11},
  pages={1984-95}
}
AIMS To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP-obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). DESIGN Hepatitis C virus HCV transmission modelling using U.K. estimates for effect of OST and 100%NSP on individual risk of HCV infection. SETTING Range of chronic HCV prevalent (20/40/60%) settings with no OST/100%NSP, and U.K. setting with 50% coverage… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 63 extracted citations

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Liver international : official journal of the International Association for the Study of the Liver • 2018

Similar Papers

Loading similar papers…